HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akishi Ooi Selected Research

ErbB-2 Receptor

7/2002Detection of c-erbB-2 (HER-2/neu) amplification in breast carcinoma by fluorescence in situ hybridization on tissue sections and imprinted cells.
4/2002Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.
1/2002Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akishi Ooi Research Topics

Disease

40Neoplasms (Cancer)
01/2021 - 01/2002
20Carcinoma (Carcinomatosis)
06/2020 - 04/2002
9Stomach Neoplasms (Stomach Cancer)
01/2017 - 04/2002
8Neoplasm Metastasis (Metastasis)
12/2012 - 01/2003
7Breast Neoplasms (Breast Cancer)
05/2021 - 01/2002
7Adenocarcinoma
04/2014 - 04/2002
4Sarcoma (Soft Tissue Sarcoma)
01/2013 - 01/2006
4Colorectal Neoplasms (Colorectal Cancer)
12/2012 - 09/2003
4Lymphatic Metastasis
09/2005 - 01/2003
3Esophageal Squamous Cell Carcinoma
11/2015 - 07/2005
3Osteosarcoma (Osteogenic Sarcoma)
08/2014 - 08/2011
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2019
2Cholangiocarcinoma
09/2013 - 11/2012
2Carcinogenesis
01/2009 - 01/2004
2Malignant Fibrous Histiocytoma
06/2007 - 12/2004
1Noninfiltrating Intraductal Carcinoma (DCIS)
06/2020
1Ganglion Cysts (Ganglion)
09/2018
1Diabetes Mellitus
02/2018
1Hyperglycemia
02/2018
1Multiple Myeloma
02/2018
1Thyroid Diseases (Thyroid Disease)
05/2015
1Lobular Carcinoma
05/2014
1Ductal Carcinoma
05/2014
1Malignant Mesothelioma
01/2014
1Glioma (Gliomas)
07/2013
1Glioblastoma (Glioblastoma Multiforme)
07/2013
1Myxoid Liposarcoma
01/2013
1Hepatocellular Carcinoma (Hepatoma)
11/2012
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
11/2012
1Margins of Excision
08/2011

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2002
11ParaffinIBA
01/2019 - 01/2002
11ErbB Receptors (EGF Receptor)IBA
09/2012 - 11/2003
10Formaldehyde (Formol)FDA Link
01/2019 - 01/2002
5Biological ProductsIBA
08/2014 - 01/2003
4Phosphotransferases (Kinase)IBA
01/2020 - 11/2003
4Monoclonal AntibodiesIBA
04/2014 - 04/2002
4TOR Serine-Threonine KinasesIBA
09/2012 - 01/2009
4fibroblast activation protein alphaIBA
09/2005 - 01/2003
4GelatinasesIBA
09/2005 - 01/2003
4Serine Proteases (Serine Protease)IBA
09/2005 - 01/2003
3tyrosine receptor (receptor, tyrosine)IBA
01/2020 - 11/2003
3Cyclin D1IBA
01/2018 - 07/2004
3Protein Kinases (Protein Kinase)IBA
06/2007 - 12/2004
3Trastuzumab (Herceptin)FDA Link
07/2005 - 04/2002
3ErbB-2 ReceptorIBA
07/2002 - 01/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2020 - 11/2010
2Pharmaceutical PreparationsIBA
02/2018 - 12/2003
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2017 - 12/2003
2Protein Isoforms (Isoforms)IBA
06/2015 - 01/2014
2Biomarkers (Surrogate Marker)IBA
01/2015 - 01/2014
2Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2013 - 11/2012
2Peptide Initiation Factors (Initiation Factor)IBA
02/2011 - 10/2009
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2010 - 07/2005
2DNA (Deoxyribonucleic Acid)IBA
08/2004 - 07/2004
1Immune Checkpoint ProteinsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1LigandsIBA
01/2021
1Estrogen ReceptorsIBA
06/2020
1Transforming Growth Factor-beta Type I ReceptorIBA
06/2020
1Phenobarbital (Luminal)FDA Link
06/2020
1Transforming Growth Factor beta (TGF-beta)IBA
06/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2019
1I-kappa B KinaseIBA
01/2019
1ChromatinIBA
09/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
02/2018
1Insulin (Novolin)FDA Link
02/2018
1Lenalidomide (CC 5013)FDA Link
02/2018
1Bortezomib (Velcade)FDA Link
02/2018
1Clarithromycin (Biaxin)FDA LinkGeneric
02/2018
1Cyclin EIBA
01/2017
1UbiquitinIBA
01/2017
1Ligases (Synthetase)IBA
01/2017
1MicroRNAs (MicroRNA)IBA
10/2016
1human ERBB2 proteinIBA
01/2015
1Cadherins (E-Cadherin)IBA
05/2014
1DesminIBA
01/2014
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2013
1MethyltransferasesIBA
07/2013
1ElementsIBA
12/2012
1NucleotidesIBA
12/2012
1Fetal Proteins (Fetoprotein)IBA
11/2012
1GlypicansIBA
11/2012
1Epithelial Cell Adhesion MoleculeIBA
11/2012
1Ribosomal Protein S6IBA
02/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2010
1AntibodiesIBA
11/2010
1Platelet-Derived Growth FactorIBA
11/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2010

Therapy/Procedure

16Therapeutics
01/2019 - 04/2002
11Drug Therapy (Chemotherapy)
01/2015 - 11/2003
8Ligation
01/2020 - 04/2014
1Radiotherapy
01/2020
1Molecular Targeted Therapy
01/2020
1Punctures
09/2018
1Combination Drug Therapy (Combination Chemotherapy)
02/2018
1Operative Surgical Procedures
05/2015
1Distraction Osteogenesis
08/2014
1Neoadjuvant Therapy
04/2014
1Chemoradiotherapy
07/2013